Could less medicine be better? major trial tests lower doses for blood cancers
NCT ID NCT07474961
Summary
This large trial aims to find the best dose for blood cancer drugs, testing if lower doses can control the disease just as well while causing fewer side effects. It will enroll 400 adults with conditions like multiple myeloma and Waldenstrom's macroglobulinemia. The study uses a flexible 'platform' design to test different drugs and doses over time, focusing on survival, quality of life, and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aalborg University Hospital
Aalborg, 9000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Aarhus University Hospital
Aarhus, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Copenhagen University Hospital - Rigshospitalet
Copenhagen, Greater Copenhagen Area, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Odense University Hospital
Odense, 5000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Roskilde University Hospital
Roskilde, 4000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.